Clinical Trial: GLP-1 Agonists for Prevention of Recurrent Hypertriglyceridemic Acute Pancreatitis

U.S., June 2 -- ClinicalTrials.gov registry received information related to the study (NCT07617155) titled 'GLP-1 Agonists for Prevention of Recurrent Hypertriglyceridemic Acute Pancreatitis' on May 14.

Brief Summary: Hypertriglyceridemia-induced acute pancreatitis (HTG-AP) is associated with a high risk of recurrence despite standard lipid-lowering therapy and lifestyle modification. The goal of this clinical trial is to evaluate whether GLP-1 receptor agonist therapy can reduce the recurrence of HTG-AP in adults with a history of HTG-AP and hypertriglyceridemia.

The main questions this study aims to answer are:

* Whether GLP-1 receptor agonist therapy reduces the recurrence rate of HTG-AP.

* Whether GLP-1 receptor agonist therapy impr...